Koninklijke Philips (RYLPF) Other Non-Current Assets (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Other Non-Current Assets of $828.9 million in Q1 2026, up 1.15% quarter-over-quarter from $819.5 million in Q4 2025, and up 31.33% on a YoY basis from $631.1 million in Q1 2025.
Koninklijke Philips (RYLPF) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Koninklijke Philips' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $828.9 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 31.33% year-over-year to $828.9 million; the TTM figure through Mar 2026 stood at $828.9 million (up 31.33% YoY), while the FY2025 annual figure was $819.5 million, up 503.84% from the prior year.
- Other Non-Current Assets was $828.9 million for Q1 2026 at Koninklijke Philips, up from $819.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $828.9 million in Q1 2026 to a low of $135.7 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $650.3 million across 5 years, with a median of $673.4 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 79.62% in 2024, then soared 503.84% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $673.4 million in 2022, then fell by 1.09% to $666.0 million in 2023, then sank by 79.62% to $135.7 million in 2024, then jumped by 503.84% to $819.5 million in 2025, then grew by 1.15% to $828.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $828.9 million (Q1 2026), $819.5 million (Q4 2025), and $723.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 828.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 828.89 Mn |
| Dec 31, 2025 | 819.49 Mn |
| Sep 30, 2025 | 723.65 Mn |
| Jun 30, 2025 | 629.37 Mn |
| Mar 31, 2025 | 631.13 Mn |
| Dec 31, 2024 | 135.71 Mn |
| Jun 30, 2024 | 669.82 Mn |
| Dec 31, 2023 | 666.01 Mn |
| Jun 30, 2023 | 692.56 Mn |
| Dec 31, 2022 | 673.36 Mn |
| Jun 30, 2022 | 682.92 Mn |
| Dec 31, 2021 | 720.70 Mn |
| Jun 30, 2021 | 668.37 Mn |
| Dec 31, 2020 | 512.68 Mn |
| Jun 30, 2020 | 435.08 Mn |
| Dec 31, 2019 | 274.51 Mn |
| Jun 30, 2019 | 370.80 Mn |
| Dec 31, 2018 | 410.90 Mn |
| Jun 30, 2018 | 665.94 Mn |
| Dec 31, 2017 | 691.15 Mn |